The LifePort liver perfusion device is an innovative technology for liver perfusion and transplantation. It is based on the successful LifePort kidney transport platform, which has been used by transplant surgeons in more than 200,000 procedures worldwide. The system is designed to maintain liver viability, ensure safety, and improve clinical outcomes.
Key features:
- Double perfusion: Accurate hepatic artery and portal vein perfusion.
- Programmable display: Real-time data on organ ID, blood type, perfusion time, temperature, flow and pressure.
- Security system: The redundant system combines dynamic perfusion and static cooling, ensuring maximum organ safety.
Clinical trials:
- PILOT™ study: Comparing cold storage and hypothermic machine perfusion, it was found that patients who received perfused livers experienced fewer complications and had a shorter hospitalization period (13.6 vs. 21.1 days).
- PILOT_CA study: Confirmed the benefits of perfusion using extended criteria livers, which are often rejected in other transplant centers.
Advantages of technology:
- Reduces the risk of complications: Hypothermic perfusion reduces the incidence of early graft dysfunction and biliary tract complications.
- Increases the availability of donor livers: Using perfusion, organs that were previously considered unsuitable can be properly prepared for transplantation.
- Shortens hospitalization time: Studies show that patients who receive a perfused liver recover and are discharged from the hospital more quickly.
EN 
LT 
LV